Graseby hit by NHS purchasing changes:
This article was originally published in Clinica
UK electronic instruments company Graseby recorded a 17% decline in medical product sales in the first quarter of 1996 compared with the same period a year ago. The drop is attributed to changing purchasing patterns by UK NHS trusts which can now carry over expenditure budgets from one fiscal year to the next.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.